Cited by 71MicroRNA in disease regulationNeuroinflammation and Neurodegeneration MechanismsCancer-related molecular mechanisms research

Non-Coding RNAs in Stroke and Neuroprotection

Open access
Saugstad, Julie A.·2015·Frontiers in Neurology

Abstract

This review will focus on the current state of knowledge regarding non-coding RNAs (ncRNA) in stroke and neuroprotection. There will be a brief introduction to microRNAs (miRNA), long ncRNAs (lncRNA), and piwi-interacting RNAs (piRNA), followed by evidence for the regulation of ncRNAs in ischemia. This review will also discuss the effect of neuroprotection induced by a sublethal duration of ischemia or other stimuli given before a stroke (preconditioning) on miRNA expression and the role of miRNAs in preconditioning-induced neuroprotection. Experimental manipulation of miRNAs and/or their targets to induce pre- or post-stroke protection will also be presented, as well as discussion on miRNA responses to current post-stroke therapies. This review will conclude with a brief discussion of future directions for ncRNAs studies in stroke, such as new approaches to model complex ncRNA datasets, challenges in ncRNA studies, and the impact of extracellular RNAs on human diseases such as stroke.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fneur.2015.00050

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 122 · Cited by 71

Research works printed but not linked: 113

  1. [1]Vemuganti R. All’s well that transcribes well: non-coding RNAs and post- stroke brain damage. Neurochem Int (2013) 63: 438– 49. 10.1016/j.neuint.2013.07.014 23954844 PMC3805745 · DOI · Paper page
  2. [2]Bhalala OG Srikanth M Kessler JA. The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol (2013) 9: 328– 39. 10.1038/nrneurol.2013.67 23588363 PMC3755895 · DOI
  3. [3]Yin KJ Hamblin M Chen YE. Non-coding RNAs in cerebral endothelial pathophysiology: emerging roles in stroke. Neurochem Int (2014) 77: 9– 16. 10.1016/j.neuint.2014.03.013 24704794 PMC4177278 · DOI
  4. [4]Yan H Fang M Liu XY. Role of microRNAs in stroke and poststroke depression. ScientificWorldJournal (2013) 2013: 459692. 10.1155/2013/459692 24363618 PMC3865697 · DOI
  5. [5]Wang Y Wang Y Yang GY MicroRNAs in cerebral ischemia. Stroke Res Treat (2013) 2013: 276540 10.1155/2013/276540 23533957 PMC3606790 · DOI
  6. [6]Liu XS Chopp M Zhang RL Zhang ZG. MicroRNAs in cerebral ischemia-induced neurogenesis. J Neuropathol Exp Neurol (2013) 72: 718– 22. 10.1097/NEN.0b013e31829e4963 23860031 PMC3746334 · DOI
  7. [7]Liu FJ Lim KY Kaur P Sepramaniam S Armugam A Wong PT microRNAs involved in regulating spontaneous recovery in embolic stroke model. PLoS One (2013) 8: e66393. 10.1371/journal.pone.0066393 23823624 PMC3688919 · DOI
  8. [8]Kukreja RC Yin C Salloum FN. MicroRNAs: new players in cardiac injury and protection. Mol Pharmacol (2011) 80: 558– 64. 10.1124/mol.111.073528 21737570 PMC3187527 · DOI
  9. [9]Lodish HF Translational control of protein synthesis. Annu Rev Biochem (1976) 45: 39– 72 10.1146/annurev.bi.45.070176.000351 786155 · DOI
  10. [10]Cech TR Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell (2014) 157: 77– 94. 10.1016/j.cell.2014.03.008 24679528 · DOI · Paper page
  11. [12]Bratkovic T Rogelj B. The many faces of small nucleolar RNAs. Biochim Biophys Acta (2014) 1839: 438– 43. 10.1016/j.bbagrm.2014.04.009 24735946 · DOI
  12. [13]Filipowicz W Jaskiewicz L Kolb FA Pillai RS. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol (2005) 15: 331– 41. 10.1016/j.sbi.2005.05.006 15925505 · DOI
  13. [14]Kaur P Liu F Tan JR Lim KY Sepramaniam S Karolina DS Non-coding RNAs as potential neuroprotectants against ischemic brain injury. Brain Sci (2013) 3: 360– 95. 10.3390/brainsci3010360 24961318 PMC4061830 · DOI
  14. [16]Iyengar BR Choudhary A Sarangdhar MA Venkatesh KV Gadgil CJ Pillai B. Non-coding RNA interact to regulate neuronal development and function. Front Cell Neurosci (2014) 8: 47. 10.3389/fncel.2014.00047 24605084 PMC3932439 · DOI
  15. [17]Petri R Malmevik J Fasching L Akerblom M Jakobsson J miRNAs in brain development. Exp Cell Res (2014) 321: 84– 9 10.1016/j.yexcr.2013.09.022 24099990 · DOI
  16. [18]Sun E Shi Y. MicroRNAs: small molecules with big roles in neurodevelopment and diseases. Exp Neurol (2014). 10.1016/j.expneurol.2014.08.005 25128264 · DOI
  17. [19]Conaco C Otto S Han JJ Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A (2006) 103: 2422– 7. 10.1073/pnas.0511041103 16461918 PMC1413753 · DOI · Paper page
  18. [21]Fiore R Khudayberdiev S Christensen M Siegel G Flavell SW Kim TK Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J (2009) 28: 697– 710. 10.1038/emboj.2009.10 19197241 PMC2647767 · DOI · Paper page
  19. [22]Magill ST Cambronne XA Luikart BW Lioy DT Leighton BH Westbrook GL microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci U S A (2010) 107: 20382– 7. 10.1073/pnas.1015691107 21059906 PMC2996687 · DOI
  20. [23]Schratt GM Tuebing F Nigh EA Kane CG Sabatini ME Kiebler M A brain-specific microRNA regulates dendritic spine development. Nature (2006) 439: 283– 9. 10.1038/nature04367 16421561 · DOI · Paper page
  21. [24]Aksoy-Aksel A Zampa F Schratt G. MicroRNAs and synaptic plasticity – a mutual relationship. Philos Trans R Soc Lond B Biol Sci (2014) 369: 20130515. 10.1098/rstb.2013.0515 25135976 PMC4142036 · DOI
  22. [25]Bredy TW Lin Q Wei W Baker-Andresen D Mattick JS MicroRNA regulation of neural plasticity and memory. Neurobiol Learn Mem (2011) 96: 89– 94 10.1016/j.nlm.2011.04.004 21524708 · DOI
  23. [26]Olde Loohuis NF Kos A Martens GJ Van Bokhoven H Nadif Kasri N Aschrafi A. MicroRNA networks direct neuronal development and plasticity. Cell Mol Life Sci (2012) 69: 89– 102. 10.1007/s00018-011-0788-1 21833581 PMC3249201 · DOI
  24. [27]Paschou M Paraskevopoulou MD Vlachos IS Koukouraki P Hatzigeorgiou AG Doxakis E. miRNA regulons associated with synaptic function. PLoS One (2012) 7: e46189. 10.1371/journal.pone.0046189 23071543 PMC3468272 · DOI
  25. [28]Siegel G Saba R Schratt G. microRNAs in neurons: manifold regulatory roles at the synapse. Curr Opin Genet Dev (2011) 21: 491– 7. 10.1016/j.gde.2011.04.008 21561760 · DOI
  26. [29]Tognini P Pizzorusso T. MicroRNA212/132 family: molecular transducer of neuronal function and plasticity. Int J Biochem Cell Biol (2012) 44: 6– 10. 10.1016/j.biocel.2011.10.015 22062950 · DOI
  27. [30]Wibrand K Pai B Siripornmongcolchai T Bittins M Berentsen B Ofte ML MicroRNA regulation of the synaptic plasticity-related gene Arc. PLoS One (2012) 7: e41688. 10.1371/journal.pone.0041688 22844515 PMC3406043 · DOI
  28. [31]Chivet M Javalet C Hemming F Pernet-Gallay K Laulagnier K Fraboulet S Exosomes as a novel way of interneuronal communication. Biochem Soc Trans (2013) 41: 241– 4. 10.1042/BST20120266 23356290 · DOI
  29. [32]Fruhbeis C Frohlich D Kuo WP Kramer-Albers EM. Extracellular vesicles as mediators of neuron-glia communication. Front Cell Neurosci (2013) 7: 182. 10.3389/fncel.2013.00182 24194697 PMC3812991 · DOI
  30. [33]Sharma P Schiapparelli L Cline HT. Exosomes function in cell-cell communication during brain circuit development. Curr Opin Neurobiol (2013) 23: 997– 1004. 10.1016/j.conb.2013.08.005 23998929 PMC3830597 · DOI
  31. [34]Rajendran L Bali J Barr MM Court FA Kramer-Albers EM Picou F Emerging roles of extracellular vesicles in the nervous system. J Neurosci (2014) 34: 15482– 9. 10.1523/JNEUROSCI.3258-14.2014 25392515 PMC4228143 · DOI · Paper page
  32. [35]Garnier D Jabado N Rak J. Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours. Proteomics (2013) 13: 1595– 607. 10.1002/pmic.201200360 23505048 · DOI
  33. [36]El Andaloussi S Mager I Breakefield XO Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 12: 347– 57. 10.1038/nrd3978 23584393 · DOI · Paper page
  34. [37]Mercer TR Dinger ME Mattick JS Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 10: 155– 9 10.1038/nrg2521 19188922 · DOI · Paper page
  35. [38]Yoon JH Abdelmohsen K Gorospe M Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol (2013) 425(19): 3723– 30 10.1016/j.jmb.2012.11.024 23178169 PMC3594629 · DOI
  36. [39]Mercer TR Dinger ME Sunkin SM Mehler MF Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A (2008) 105: 716– 21. 10.1073/pnas.0706729105 18184812 PMC2206602 · DOI · Paper page
  37. [40]Qureshi IA Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci (2012) 13: 528– 41. 10.1038/nrn3234 22814587 PMC3478095 · DOI
  38. [41]Qureshi IA Mattick JS Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res (2010) 1338: 20– 35. 10.1016/j.brainres.2010.03.110 20380817 PMC2883659 · DOI
  39. [42]Qureshi IA Mehler MF. Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics (2013) 10: 632– 46. 10.1007/s13311-013-0199-0 23817781 PMC3805860 · DOI
  40. [43]Weick EM Miska EA. piRNAs: from biogenesis to function. Development (2014) 141: 3458– 71. 10.1242/dev.094037 25183868 · DOI
  41. [44]Meister G. Argonaute proteins: functional insights and emerging roles. Nat Rev Genet (2013) 14: 447– 59. 10.1038/nrg3462 23732335 · DOI
  42. [45]Das PP Bagijn MP Goldstein LD Woolford JR Lehrbach NJ Sapetschnig A Piwi and piRNAs act upstream of an endogenous siRNA pathway to suppress Tc3 transposon mobility in the Caenorhabditis elegans germline. Mol Cell (2008) 31: 79– 90. 10.1016/j.molcel.2008.06.003 18571451 PMC3353317 · DOI
  43. [46]Houwing S Kamminga LM Berezikov E Cronembold D Girard A van den Elst H A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in Zebrafish. Cell (2007) 129: 69– 82. 10.1016/j.cell.2007.03.026 17418787 · DOI
  44. [47]Vagin VV Sigova A Li C Seitz H Gvozdev V Zamore PD. A distinct small RNA pathway silences selfish genetic elements in the germline. Science (2006) 313: 320– 4. 10.1126/science.1129333 16809489 · DOI
  45. [48]Malone CD Hannon GJ. Small RNAs as guardians of the genome. Cell (2009) 136: 656– 68. 10.1016/j.cell.2009.01.045 19239887 PMC2792755 · DOI
  46. [49]Landry CD Kandel ER Rajasethupathy P. New mechanisms in memory storage: piRNAs and epigenetics. Trends Neurosci (2013) 36: 535– 42. 10.1016/j.tins.2013.05.004 23827695 · DOI
  47. [50]Jeyaseelan K Lim KY Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke (2008) 39: 959– 66. 10.1161/STROKEAHA.107.500736 18258830 · DOI
  48. [51]Dharap A Bowen K Place R Li LC Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab (2009) 29: 675– 87. 10.1038/jcbfm.2008.157 19142192 PMC2743462 · DOI
  49. [52]Tan KS Armugam A Sepramaniam S Lim KY Setyowati KD Wang CW Expression profile of MicroRNAs in young stroke patients. PLoS One (2009) 4: e7689. 10.1371/journal.pone.0007689 19888324 PMC2765616 · DOI
  50. [53]Wang C Pan Y Cheng B Chen J Bai B. Identification of conserved and novel micrornas in cerebral ischemia-reperfusion injury of rat using deep sequencing. J Mol Neurosci (2014) 54(4): 671– 83. 10.1007/s12031-014-0383-7 25063377 · DOI
  51. [54]Murphy SJ McCullough LD Smith JM. Stroke in the female: role of biological sex and estrogen. ILAR J (2004) 45: 147– 59. 10.1093/ilar.45.2.147 15111734 · DOI
  52. [55]Siegel C Li J Liu F Benashski SE McCullough LD. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci U S A (2011) 108: 11662– 7. 10.1073/pnas.1102635108 21709246 PMC3136267 · DOI
  53. [56]Lusardi TA Murphy SJ Phillips JI Chen Y Davis CM Young JM MicroRNA responses to focal cerebral ischemia in male and female mouse brain. Front Mol Neurosci (2014) 7: 11. 10.3389/fnmol.2014.00011 24574964 PMC3920114 · DOI
  54. [57]Murphy SJ Lusardi TA Phillips JI Saugstad JA. Sex differences in microRNA expression during development in rat cortex. Neurochem Int (2014) 77: 24– 32. 10.1016/j.neuint.2014.06.007 24969725 PMC4177314 · DOI
  55. [58]Selvamani A Williams MH Miranda RC Sohrabji F. Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. Clin Sci (Lond) (2014) 127: 77– 89. 10.1042/CS20130565 24428837 PMC4386587 · DOI
  56. [59]Yin KJ Deng Z Huang H Hamblin M Xie C Zhang J miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis (2010) 38(1): 17– 26. 10.1016/j.nbd.2009.12.021 20053374 PMC2837803 · DOI
  57. [60]Chen J Simon RP Nagayama T Zhu R Loeffert JE Watkins SC Suppression of endogenous bcl-2 expression by antisense treatment exacerbates ischemic neuronal death. J Cereb Blood Flow Metab (2000) 20: 1033– 9. 10.1097/00004647-200007000-00002 10908036 · DOI
  58. [61]Linnik MD Zahos P Geschwind MD Federoff HJ. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke (1995) 26: 1670– 4. 10.1161/01.STR.26.9.1670 7544927 · DOI
  59. [62]Martinou JC Dubois-Dauphin M Staple JK Rodriguez I Frankowski H Missotten M Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron (1994) 13: 1017– 30. 10.1016/0896-6273(94)90266-6 7946326 · DOI
  60. [63]Sun Y Jin K Clark KR Peel A Mao XO Chang Q Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemia. Gene Ther (2003) 10: 115– 22. 10.1038/sj.gt.3301868 12571640 · DOI
  61. [64]Shi G Liu Y Liu T Yan W Liu X Wang Y Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury. Exp Brain Res (2012) 216: 225– 30. 10.1007/s00221-011-2925-3 22094713 · DOI
  62. [65]Huang W Liu X Cao J Meng F Li M Chen B miR-134 regulates ischemia/reperfusion injury-induced neuronal cell death by regulating CREB signaling. J Mol Neurosci (2014) 2: 1– 9. 10.1007/s12031-014-0434-0 25316150 · DOI
  63. [67]Gubern C Camos S Ballesteros I Rodriguez R Romera VG Canadas R miRNA expression is modulated over time after focal ischaemia: up-regulation of miR-347 promotes neuronal apoptosis. FEBS J (2013) 280: 6233– 46. 10.1111/febs.12546 24112606 · DOI
  64. [68]Ziu M Fletcher L Rana S Jimenez DF Digicaylioglu M. Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS One (2011) 6: e14724. 10.1371/journal.pone.0014724 21373187 PMC3044134 · DOI
  65. [69]Ouyang YB Lu Y Yue S Xu LJ Xiong XX White RE miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis (2012) 45: 555– 63. 10.1016/j.nbd.2011.09.012 21983159 PMC3251314 · DOI
  66. [70]Ouyang YB Giffard RG. MicroRNAs regulate the chaperone network in cerebral ischemia. Transl Stroke Res (2013) 4: 693– 703. 10.1007/s12975-013-0280-3 24323423 PMC3864745 · DOI
  67. [71]Dhiraj DK Chrysanthou E Mallucci GR Bushell M. miRNAs-19b, -29b-2* and -339-5p show an early and sustained up-regulation in ischemic models of stroke. PLoS One (2013) 8: e83717. 10.1371/journal.pone.0083717 24376737 PMC3869799 · DOI
  68. [72]Dharap A Nakka VP Vemuganti R. Effect of focal ischemia on long noncoding RNAs. Stroke (2012) 43: 2800– 2. 10.1161/STROKEAHA.112.669465 22949471 PMC3458128 · DOI
  69. [73]Dharap A Pokrzywa C Vemuganti R. Increased binding of stroke-induced long non-coding RNAs to the transcriptional corepressors Sin3A and coREST. ASN Neuro (2013) 5: 283– 9. 10.1042/AN20130029 24063527 PMC3806319 · DOI
  70. [74]Lee EJ Banerjee S Zhou H Jammalamadaka A Arcila M Manjunath BS Identification of piRNAs in the central nervous system. RNA (2011) 17: 1090– 9 10.1261/rna.2565011 21515829 PMC3096041 · DOI · Paper page
  71. [75]Dharap A Nakka VP Vemuganti R. Altered expression of PIWI RNA in the rat brain after transient focal ischemia. Stroke (2011) 42: 1105– 9. 10.1161/STROKEAHA.110.598391 21311060 PMC3566794 · DOI
  72. [76]Rejdak R Rejdak K Sieklucka-Dziuba M Stelmasiak Z Grieb P Brain tolerance and preconditioning. Pol J Pharmacol (2001) 53: 73– 9. 11785917
  73. [77]Stetler RA Leak RK Gan Y Li P Zhang F Hu X Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. Prog Neurobiol (2014) 114: 58– 83. 10.1016/j.pneurobio.2013.11.005 24389580 PMC3937258 · DOI
  74. [78]Barone FC White RF Spera PA Ellison J Currie RW Wang X Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke (1998) 29: 1937– 50. 10.1161/01.STR.29.9.1937 9731622 · DOI
  75. [79]Stenzel-Poore MP Stevens SL King JS Simon RP. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke (2007) 38: 680– 5. 10.1161/01.STR.0000251444.56487.4c 17261715 · DOI · Paper page
  76. [80]Stenzel-Poore MP Stevens SL Simon RP. Genomics of preconditioning. Stroke (2004) 35: 2683– 6. 10.1161/01.STR.0000143735.89281.bb 15459430 · DOI
  77. [81]Stenzel-Poore MP Stevens SL Xiong Z Lessov NS Harrington CA Mori M Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet (2003) 362: 1028– 37. 10.1016/S0140-6736(03)14412-1 14522533 · DOI
  78. [82]Kitagawa K Matsumoto M Kuwabara K Tagaya M Ohtsuki T Hata R ‘Ischemic tolerance’ phenomenon detected in various brain regions. Brain Res (1991) 561: 203– 11. 10.1016/0006-8993(91)91596-S 1802339 · DOI
  79. [83]Kitagawa K Matsumoto M Tagaya M Hata R Ueda H Niinobe M ‘Ischemic tolerance’ phenomenon found in the brain. Brain Res (1990) 528: 21– 4. 10.1016/0006-8993(90)90189-I 2245337 · DOI
  80. [84]Lusardi TA Farr CD Faulkner CL Pignataro G Yang T Lan J Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J Cereb Blood Flow Metab (2010) 30: 744– 56. 10.1038/jcbfm.2009.253 20010955 PMC2935903 · DOI
  81. [86]Feng Y Huang W Wani M Yu X Ashraf M. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One (2014) 9: e88685. 10.1371/journal.pone.0088685 24558412 PMC3928277 · DOI
  82. [87]Dharap A Vemuganti R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem (2010) 113: 1685– 91. 10.1111/j.1471-4159.2010.06735.x 20402966 PMC2919749 · DOI
  83. [88]Lee ST Chu K Jung KH Yoon HJ Jeon D Kang KM MicroRNAs induced during ischemic preconditioning. Stroke (2010) 41: 1646– 51. 10.1161/STROKEAHA.110.579649 20576953 · DOI
  84. [89]Bu X Zhang N Yang X Liu Y Du J Liang J Proteomic analysis of cPKCbetaII-interacting proteins involved in HPC-induced neuroprotection against cerebral ischemia of mice. J Neurochem (2011) 117: 346– 56. 10.1111/j.1471-4159.2011.07209.x 21291475 · DOI
  85. [90]Liu C Peng Z Zhang N Yu L Han S Li D Identification of differentially expressed microRNAs and their PKC-isoform specific gene network prediction during hypoxic pre-conditioning and focal cerebral ischemia of mice. J Neurochem (2012) 120: 830– 41. 10.1111/j.1471-4159.2011.07624.x 22171942 · DOI
  86. [91]Kitano H Kirsch JR Hurn PD Murphy SJ. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab (2007) 27: 1108– 28. 10.1038/sj.jcbfm.9600410 17047683 PMC2266688 · DOI
  87. [92]Cao L Feng C Li L Zuo Z. Contribution of microRNA-203 to the isoflurane preconditioning-induced neuroprotection. Brain Res Bull (2012) 88: 525– 8. 10.1016/j.brainresbull.2012.05.009 22609621 PMC3381978 · DOI
  88. [93]Shi H Sun BL Zhang J Lu S Zhang P Wang H miR-15b suppression of Bcl-2 contributes to cerebral ischemic injury and is reversed by sevoflurane preconditioning. CNS Neurol Disord Drug Targets (2013) 12: 381– 91. 10.2174/1871527311312030011 23469855 PMC4071288 · DOI
  89. [94]Marsh BJ Williams-Karnesky RL Stenzel-Poore MP. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience (2009) 158: 1007– 20. 10.1016/j.neuroscience.2008.07.067 18809468 PMC2674023 · DOI
  90. [95]Vartanian K Stenzel-Poore M. Toll-like receptor tolerance as a mechanism for neuroprotection. Transl Stroke Res (2010) 1: 252– 60. 10.1007/s12975-010-0033-5 21339866 PMC3040513 · DOI
  91. [97]Stevens SL Ciesielski TM Marsh BJ Yang T Homen DS Boule JL Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab (2008) 28: 1040– 7. 10.1038/sj.jcbfm.9600606 18183029 PMC3037270 · DOI
  92. [98]Vartanian KB Mitchell HD Stevens SL Conrad VK McDermott JE Stenzel-Poore MP. CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury. J Cereb Blood Flow Metab (2014) 35(2): 257– 66. 10.1038/jcbfm.2014.193 25388675 PMC4426742 · DOI
  93. [99]Lee YJ Castri P Bembry J Maric D Auh S Hallenbeck JM SUMOylation participates in induction of ischemic tolerance. J Neurochem (2009) 109: 257– 67 10.1111/j.1471-4159.2009.05957.x 19200349 PMC2692380 · DOI
  94. [100]Lee YJ Miyake S Wakita H McMullen DC Azuma Y Auh S Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J Cereb Blood Flow Metab (2007) 27: 950– 62. 10.1038/sj.jcbfm.9600395 16955077 PMC2396349 · DOI · Paper page
  95. [101]Lee YJ Johnson KR Hallenbeck JM. Global protein conjugation by ubiquitin-like-modifiers during ischemic stress is regulated by microRNAs and confers robust tolerance to ischemia. PLoS One (2012) 7: e47787. 10.1371/journal.pone.0047787 23094087 PMC3475703 · DOI
  96. [102]Pandi G Nakka VP Dharap A Roopra A Vemuganti R. MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage. PLoS One (2013) 8: e58039. 10.1371/journal.pone.0058039 23516428 PMC3596316 · DOI
  97. [103]Hwang JY Kaneko N Noh KM Pontarelli F Zukin RS. The gene silencing transcription factor REST represses miR-132 expression in hippocampal neurons destined to die. J Mol Biol (2014) 426: 3454– 66. 10.1016/j.jmb.2014.07.032 25108103 PMC4373704 · DOI
  98. [104]Peng Z Li J Li Y Yang X Feng S Han S Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1. J Neurosci Res (2013) 91: 1349– 62. 10.1002/jnr.23255 23900885 · DOI
  99. [105]Chi W Meng F Li Y Li P Wang G Cheng H Impact of microRNA-134 on neural cell survival against ischemic injury in primary cultured neuronal cells and mouse brain with ischemic stroke by targeting HSPA12B. Brain Res (2014) 1592: 22– 33. 10.1016/j.brainres.2014.09.072 25304362 · DOI
  100. [106]Wang P Liang J Li Y Li J Yang X Zhang X Down-regulation of miRNA-30a alleviates cerebral ischemic injury through enhancing beclin 1-mediated autophagy. Neurochem Res (2014) 39: 1279– 91. 10.1007/s11064-014-1310-6 24771295 · DOI
  101. [107]Di Y Lei Y Yu F Changfeng F Song W Xuming M. MicroRNAs expression and function in cerebral ischemia reperfusion injury. J Mol Neurosci (2014) 53: 242– 50. 10.1007/s12031-014-0293-8 24696166 · DOI
  102. [108]Peng T Jia YJ Wen QQ Guan WJ Zhao EY Zhang BA. [Expression of microRNA in neonatal rats with hypoxic-ischemic brain damage]. Zhongguo Dang Dai Er Ke Za Zhi (2010) 12: 373– 6. 20497647
  103. [109]Zhu F Liu JL Li JP Xiao F Zhang ZX Zhang L. MicroRNA-124 (miR-124) regulates Ku70 expression and is correlated with neuronal death induced by ischemia/reperfusion. J Mol Neurosci (2014) 52: 148– 55. 10.1007/s12031-013-0155-9 24166354 · DOI
  104. [110]Zhao H Wang J Gao L Wang R Liu X Gao Z MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke (2013) 44: 1706– 13. 10.1161/STROKEAHA.111.000504 23613494 · DOI · Paper page
  105. [111]Pignataro G Gala R Cuomo O Tortiglione A Giaccio L Castaldo P Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia. Stroke (2004) 35: 2566– 70. 10.1161/01.STR.0000143730.29964.93 15472108 · DOI
  106. [112]Vinciguerra A Formisano L Cerullo P Guida N Cuomo O Esposito A MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits. Mol Ther (2014) 22: 1829– 38. 10.1038/mt.2014.113 24954474 PMC4428397 · DOI
  107. [113]Shin JH Park YM Kim DH Moon GJ Bang OY Ohn T Ischemic brain extract increases SDF-1 expression in astrocytes through the CXCR2/miR-223/miR-27b pathway. Biochim Biophys Acta (2014) 1839: 826– 36. 10.1016/j.bbagrm.2014.06.019 24999035 · DOI
  108. [114]Ouyang YB Xu L Yue S Liu S Giffard RG. Neuroprotection by astrocytes in brain ischemia: importance of microRNAs. Neurosci Lett (2014) 565: 53– 8. 10.1016/j.neulet.2013.11.015 24269978 PMC3972331 · DOI
  109. [115]Hunsberger JG Fessler EB Wang Z Elkahloun AG Chuang DM. Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia. Am J Transl Res (2012) 4: 316– 32. 22937209 PMC3426385
  110. [116]Zhang L Chopp M Liu X Teng H Tang T Kassis H Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway. Arterioscler Thromb Vasc Biol (2012) 32: 1856– 64. 10.1161/ATVBAHA.112.252619 22723435 PMC3412625 · DOI
  111. [118]Bake S Selvamani A Cherry J Sohrabji F. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats. PLoS One (2014) 9: e91427. 10.1371/journal.pone.0091427 24618563 PMC3949985 · DOI
  112. [119]Xiao S Ma Y Zhu H Sun H Yin Y Feng G. miRNA functional synergistic network analysis of mice with ischemic stroke. Neurol Sci (2014) 36(1): 143– 8. 10.1007/s10072-014-1904-4 25108467 · DOI
  113. [120]Colombo E Borgiani B Verderio C Furlan R. Microvesicles: novel biomarkers for neurological disorders. Front Physiol (2012) 3: 63. 10.3389/fphys.2012.00063 22479250 PMC3315111 · DOI

Authors
Saugstad, J. A.
Affiliations
Oregon Health & Science University (US)
Corresponding author
Saugstad, Julie A.
Venue
Frontiers in Neurology
Published
2015-03-13
Volume
6
Pages
50-50
ISSN
1664-2295 (ISSN-L)
OpenAlex
W2074093758
Cited by
71
References
122
Citations by year
2025: 1 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 8 · 2019: 8 · 2018: 9 · 2017: 15 · 2016: 12
FWCI
1.17
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Neurology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R21NS082832, R01NS064270, R42NS065515)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
non-coding RNA, stroke, neuroprotection, microRNA, long non-coding RNA, piRNA, ischemia, preconditioning, ischemic stroke, extracellular RNA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review